These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 35085800)

  • 1. Tumor-acidity and bioorthogonal chemistry-mediated construction and deconstruction of drug depots for ferroptosis under normoxia and hypoxia.
    Zhou J; Wang K; Jiang M; Li J; Yuan Y
    Acta Biomater; 2022 Apr; 142():253-263. PubMed ID: 35085800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Acidity and Bioorthogonal Chemistry-Mediated On-Site Size Transformation Clustered Nanosystem to Overcome Hypoxic Resistance and Enhance Chemoimmunotherapy.
    Wang K; Jiang M; Zhou J; Liu Y; Zong Q; Yuan Y
    ACS Nano; 2022 Jan; 16(1):721-735. PubMed ID: 34978422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendrimer/metal-phenolic nanocomplexes encapsulating CuO
    Huang H; Guo H; Liu J; Ni C; Xia L; Cao X; Xia J; Shi X; Guo R
    Acta Biomater; 2024 Jul; 183():252-263. PubMed ID: 38801869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A tumor microenvironment responsive nanoplatform with oxidative stress amplification for effective MRI-based visual tumor ferroptosis.
    Luo S; Ma D; Wei R; Yao W; Pang X; Wang Y; Xu X; Wei X; Guo Y; Jiang X; Yuan Y; Yang R
    Acta Biomater; 2022 Jan; 138():518-527. PubMed ID: 34775124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioorthogonal chemistry and illumination controlled programmed size-changeable nanomedicine for synergistic photodynamic and hypoxia-activated therapy.
    Jiang M; Liu Y; Dong Y; Wang K; Yuan Y
    Biomaterials; 2022 May; 284():121480. PubMed ID: 35390710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
    Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
    Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved Immune Response for Colorectal Cancer Therapy Triggered by Multifunctional Nanocomposites with Self-Amplifying Antitumor Ferroptosis.
    Lin X; Chen H; Deng T; Cai B; Xia Y; Xie L; Wang H; Huang C
    ACS Appl Mater Interfaces; 2024 Mar; 16(11):13481-13495. PubMed ID: 38456402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactic acid responsive sequential production of hydrogen peroxide and consumption of glutathione for enhanced ferroptosis tumor therapy.
    Zou W; Gao F; Meng Z; Cai X; Chen W; Zheng Y; Ying T; Wang L; Wu J
    J Colloid Interface Sci; 2024 Jun; 663():787-800. PubMed ID: 38442520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-Generated Reactive Oxygen Species Storm for High-Performance Ferroptosis Therapy.
    Huang L; Zhu J; Xiong W; Feng J; Yang J; Lu X; Lu Y; Zhang Q; Yi P; Feng Y; Guo S; Qiu X; Xu Y; Shen Z
    ACS Nano; 2023 Jun; 17(12):11492-11506. PubMed ID: 37283506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-responsive nanoreactors based on self-enhanced photodynamic sensitization and triggered ferroptosis for cancer synergistic therapy.
    Wang X; Wu M; Zhang X; Li F; Zeng Y; Lin X; Liu X; Liu J
    J Nanobiotechnology; 2021 Jul; 19(1):204. PubMed ID: 34238297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitor-enhanced nanocatalytic ferroptosis induction for stimuli-responsive dual-modal molecular imaging guided cancer radiosensitization.
    Zheng S; Hu H; Hou M; Zhu K; Wu Z; Qi L; Xia H; Liu G; Ren Y; Xu Y; Yan C; Zhao B
    Acta Biomater; 2023 May; 162():72-84. PubMed ID: 36931419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A strategy of "adding fuel to the flames" enables a self-accelerating cycle of ferroptosis-cuproptosis for potent antitumor therapy.
    Huang L; Zhu J; Wu G; Xiong W; Feng J; Yan C; Yang J; Li Z; Fan Q; Ren B; Li Y; Chen C; Yu X; Shen Z
    Biomaterials; 2024 Dec; 311():122701. PubMed ID: 38981152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable nanoplatform upregulates tumor microenvironment acidity for enhanced cancer therapy via synergistic induction of apoptosis, ferroptosis, and anti-angiogenesis.
    Zhang C; Wang P; Zhang YN; Lu P; Huang X; Wang Y; Ran L; Xin H; Xu X; Gao W; Sun Y; Zhang L; Zhang G
    J Nanobiotechnology; 2023 Feb; 21(1):59. PubMed ID: 36810074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic catalysis of intratumor Fe
    Yang J; Ren B; Cai H; Xiong W; Feng J; Fan Q; Li Z; Huang L; Yan C; Li Y; Chen C; Shen Z
    Biomaterials; 2025 Feb; 313():122793. PubMed ID: 39226655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy-mediated redox homeostasis-controllable nanomedicine for enhanced ferroptosis sensitivity in tumor therapy.
    Lin Y; Chen X; Yu C; Xu G; Nie X; Cheng Y; Luan Y; Song Q
    Acta Biomater; 2023 Mar; 159():300-311. PubMed ID: 36642338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amorphous ferric oxide-coating selenium core-shell nanoparticles: a self-preservation Pt(IV) platform for multi-modal cancer therapies through hydrogen peroxide depletion-mediated anti-angiogenesis, apoptosis and ferroptosis.
    Xu Z; Li Q; Zhang C; Wang P; Xu X; Ran L; Zhang L; Tian G; Zhang G
    Nanoscale; 2022 Aug; 14(32):11600-11611. PubMed ID: 35861683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxygen Self-Generating Nanoreactor Mediated Ferroptosis Activation and Immunotherapy in Triple-Negative Breast Cancer.
    Li K; Xu K; He Y; Yang Y; Tan M; Mao Y; Zou Y; Feng Q; Luo Z; Cai K
    ACS Nano; 2023 Mar; 17(5):4667-4687. PubMed ID: 36861638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Strategy of Fenton Reaction Cycloacceleration for High-Performance Ferroptosis Therapy Initiated by Tumor Microenvironment Remodeling.
    Huang L; Feng J; Zhu J; Yang J; Xiong W; Lu X; Chen S; Yang S; Li Y; Xu Y; Shen Z
    Adv Healthc Mater; 2023 Jul; 12(18):e2203362. PubMed ID: 36893770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial specific delivery of combinational chemotherapeutics to combat intratumoral heterogeneity.
    Wang K; Jiang M; Zhou J; Dong Y; Liu Y; Zong Q; Sandbhor P; Singh NDP; Yuan Y
    J Control Release; 2022 Aug; 348():1004-1015. PubMed ID: 35779654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferrocene-liposome-PEG: a robust ˙OH/lipid peroxide nano-converter for inducing tumor ferroptosis.
    Liu Y; Chen J; He Z; Luo H; Liu X; Sun Y; Ge D; Liu X; Shi W
    Biomater Sci; 2023 Jan; 11(2):542-553. PubMed ID: 36472166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.